|
| Larotaxel Basic information |
Product Name: | Larotaxel | Synonyms: | Larotaxel;PNU 100940;XRP9881;Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (1S,2S,4S,7R,8aR,9aS,10aR,12aS,12bR)-7,12a-bis(acetyloxy)-1-(benzoyloxy)-1,3,4,7,8,9,9a,10,10a,12,12a,12b-dodecahydro-2-hydroxy-5,13,13-trimethyl-8-oxo-2,6-methano-2H-cyclodeca[3,4]cyclopropa[4,5]benz[1,2-b]oxet-4-yl ester, (...;Larotaxel USP/EP/BP;Paclitaxel Impurity 36(Larotaxel);Thiabendazole Impurity 4;Larotaxel (XRP-9881) | CAS: | 156294-36-9 | MF: | C45H53NO14 | MW: | 831.9 | EINECS: | | Product Categories: | Aromatics;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;API | Mol File: | 156294-36-9.mol | |
| Larotaxel Chemical Properties |
Melting point | 170 - 174°C (dec.) | Boiling point | 889.3±65.0 °C(Predicted) | density | 1.37 | storage temp. | -20°C Freezer | solubility | Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) | form | Solid | pka | 11.20±0.46(Predicted) | color | White to Off-White |
| Larotaxel Usage And Synthesis |
Uses | Larotaxel (RPR 109881A) is a taxane analog with a broad spectrum of activity and different toxicity profile and with the possible advantages of surpassing some mechanisms of resistance and penetrating into the CNS. |
| Larotaxel Preparation Products And Raw materials |
|